Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2017 2
2018 5
2019 5
2020 2
2021 1
2022 7
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up.
Sezer Z, Pavel STI, Inal A, Yetiskin H, Kaplan B, Uygut MA, Aslan AF, Bayram A, Mazicioglu M, Kalin Unuvar G, Yuce ZT, Aydin G, Kaya RK, Ates I, Kara A, Ozdarendeli A. Sezer Z, et al. Among authors: yuce zt. Vaccines (Basel). 2024 Jan 29;12(2):140. doi: 10.3390/vaccines12020140. Vaccines (Basel). 2024. PMID: 38400124 Free PMC article.
COVID-19 Antibody Levels among Various Vaccination Groups, One-Year Antibody Follow-Up in Two University Hospitals from Western and Central Turkey.
Soylu M, Sağıroğlu P, Özarslan MA, Acet O, Yüce ZT, İzci Çetinkaya F, Durmaz S, Parkan ÖM, Akyol D, Zeytinoğlu A, Kalın Ünüvar G, Taşbakan M, Gökahmetoğlu S, Atalay MA, Durusoy İR, Çiçek C, Pullukçu H, Yıldız O, Sertöz ŞR, Erensoy MS. Soylu M, et al. Among authors: yuce zt. Vaccines (Basel). 2024 Jan 7;12(1):59. doi: 10.3390/vaccines12010059. Vaccines (Basel). 2024. PMID: 38250872 Free PMC article.
Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials.
Ozdarendeli A, Sezer Z, Pavel STI, Inal A, Yetiskin H, Kaplan B, Uygut MA, Bayram A, Mazicioglu M, Unuvar GK, Yuce ZT, Aydin G, Aslan AF, Kaya RK, Koc RC, Ates I, Kara A. Ozdarendeli A, et al. Among authors: yuce zt. Vaccine. 2023 Jan 9;41(2):380-390. doi: 10.1016/j.vaccine.2022.10.093. Epub 2022 Nov 22. Vaccine. 2023. PMID: 36460536 Free PMC article.
COVID-19: vaccination vs. hospitalization.
Uzun O, Akpolat T, Varol A, Turan S, Bektas SG, Cetinkaya PD, Dursun M, Bakan N, Ketencioglu BB, Bayrak M, Baris SA, Guner R, Gunal O, Nural S, Deniz PP, Toprak OB, Ozkan G, Gumus A, Kerget F, Ercelik M, Ataoglu O, Yuksel A, Ates G, Kutsoylu OE, Kose N, Kizilirmak D, Keskin S, Gultekin O, Coskun N, Yilmaz ES, Uslu S, Basyigit İ, Ergan B, Deveci F, Yakar MN, Zuhur C, Sagcan G, Yuce ZT, Kuluozturk M, Sezgin ME, Sezgin ENA, Havlucu Y, Cuhadaroglu C, Kilinc O, Boyaci H, Altunay H, Akti M, Dursun ZB, Kalem AK, Isik SA, Akyildiz L, Aykac N, Almaz MS, Kokturk N, Itil O. Uzun O, et al. Among authors: yuce zt. Infection. 2022 Jun;50(3):747-752. doi: 10.1007/s15010-021-01751-1. Epub 2022 Jan 4. Infection. 2022. PMID: 34984646 Free PMC article.
24 results